202 related articles for article (PubMed ID: 12566316)
1. The variant hepatocyte nuclear factor 1 activates the P1 promoter of the human alpha-folate receptor gene in ovarian carcinoma.
Tomassetti A; Mangiarotti F; Mazzi M; Sforzini S; Miotti S; Galmozzi E; Elwood PC; Canevari S
Cancer Res; 2003 Feb; 63(3):696-704. PubMed ID: 12566316
[TBL] [Abstract][Full Text] [Related]
2. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
3. The divergent 5' termini of the alpha human folate receptor (hFR) mRNAs originate from two tissue-specific promoters and alternative splicing: characterization of the alpha hFR gene structure.
Elwood PC; Nachmanoff K; Saikawa Y; Page ST; Pacheco P; Roberts S; Chung KN
Biochemistry; 1997 Feb; 36(6):1467-78. PubMed ID: 9063895
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of the human beta2-glycoprotein I (beta2-GPI) gene promoter: roles of the atypical TATA box and hepatic nuclear factor-1alpha in regulating beta2-GPI promoter activity.
Wang HH; Chiang AN
Biochem J; 2004 Jun; 380(Pt 2):455-63. PubMed ID: 14984368
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
6. Characterization of cis-acting elements and transacting factors involved in the tissue-specific and developmental regulation of IGFBP-1 gene expression.
Babajko S; Binoux M; Groyer A
Growth Regul; 1993 Mar; 3(1):17-20. PubMed ID: 7683517
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone regulates the expression of hepatocyte nuclear factor-3 gamma and other liver-enriched transcription factors in the bovine liver.
Eleswarapu S; Jiang H
J Endocrinol; 2005 Jan; 184(1):95-105. PubMed ID: 15642787
[TBL] [Abstract][Full Text] [Related]
8. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
Grasberger H; Ye H; Mashima H; Bell GI
Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
[TBL] [Abstract][Full Text] [Related]
9. Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression.
Bagnoli M; Tomassetti A; Figini M; Flati S; Dolo V; Canevari S; Miotti S
Oncogene; 2000 Sep; 19(41):4754-63. PubMed ID: 11032026
[TBL] [Abstract][Full Text] [Related]
10. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z; Maher VM; McCormick JJ
Gene; 2005 May; 351():51-9. PubMed ID: 15857802
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus.
Feriotto G; Finotti A; Breveglieri G; Treves S; Zorzato F; Gambari R
FEBS J; 2007 Sep; 274(17):4476-90. PubMed ID: 17681019
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human C-reactive protein gene expression by two synergistic IL-6 responsive elements.
Li SP; Goldman ND
Biochemistry; 1996 Jul; 35(28):9060-8. PubMed ID: 8703909
[TBL] [Abstract][Full Text] [Related]
13. Influence of the content in transcription factors on the phenotype of mouse hepatocyte-like cell lines (mhAT).
Levrat F; Vallet V; Berbar T; Miquerol L; Kahn A; Antoine B
Exp Cell Res; 1993 Dec; 209(2):307-16. PubMed ID: 8262148
[TBL] [Abstract][Full Text] [Related]
14. Regulation of CD34 expression in differentiating M1 cells.
Krause DS; Kapadia SU; Raj NB; May WS
Exp Hematol; 1997 Sep; 25(10):1051-61. PubMed ID: 9293902
[TBL] [Abstract][Full Text] [Related]
15. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression.
Park SH; Kim YS; Park BK; Hougaard S; Kim SJ
Oncogene; 2001 Mar; 20(10):1235-45. PubMed ID: 11313868
[TBL] [Abstract][Full Text] [Related]
16. Difference in responsiveness of human esophageal squamous cell carcinoma lines to epidermal growth factor for MMP-7 expression.
Xu H; Tanimoto A; Murata Y; Kimura S; Wang KY; Sasaguri Y
Int J Oncol; 2003 Aug; 23(2):469-76. PubMed ID: 12851697
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.
Seol DW; Chen Q; Zarnegar R
Oncogene; 2000 Feb; 19(9):1132-7. PubMed ID: 10713700
[TBL] [Abstract][Full Text] [Related]
18. The repressive function of AP2 transcription factor on the hepatocyte growth factor gene promoter.
Jiang JG; DeFrances MC; Machen J; Johnson C; Zarnegar R
Biochem Biophys Res Commun; 2000 Jun; 272(3):882-6. PubMed ID: 10860846
[TBL] [Abstract][Full Text] [Related]
19. Interplay of the liver-enriched trans-acting factors, DBP and HNF1, in the transactivation of human IGFBP-1 promoter.
Babajko S; Groyer A
Biochem Biophys Res Commun; 1993 Oct; 196(1):480-6. PubMed ID: 7692852
[TBL] [Abstract][Full Text] [Related]
20. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
